Mode
Text Size
Log in / Sign up

treprostinil

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of treprostinil

9 trials tracked of treprostinil: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 188 citations.

9Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 2 Phase 1 2 Other / NA 2
  1. Phase 3 Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH) Completed · 188 cited
  2. Phase 4 Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication Completed · 4 cited
  3. Phase 4 Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin Completed
  4. Phase 2 A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension Completed
  5. Phase 2 Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension Completed
  6. Phase 1 A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants Completed
Show 3 more trials
  1. Phase 1 A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus Completed
  2. N/A Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH Completed
  3. N/A A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.